The US Oncology Network has enrolled its 100,000th patient in the Centers for Medicare & Medicaid Innovation’s Oncology Care Model.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
